Efficacy of Collagenase Clostridium Histolyticum Injection, a Potential Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis: A Randomized, Open-Label, Dose-Ranging Study

MLA

Joseph Caporusso DPM, Mph, et al. “Efficacy of Collagenase Clostridium Histolyticum Injection, a Potential Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis: A Randomized, Open-Label, Dose-Ranging Study.” Foot & Ankle Orthopaedics, vol. 8, Dec. 2023. EBSCOhost, https://doi.org/10.1177/2473011423S00093.

APA

Joseph Caporusso DPM, M., Richard Pollak DPM, M., David Hernandez MD, Shannon Dalton PhD, Qinfang Xiang Ph D, Saji Vijayan MBBS, & C. James Anderson DPM. (2023). Efficacy of Collagenase Clostridium Histolyticum Injection, a Potential Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis: A Randomized, Open-Label, Dose-Ranging Study. Foot & Ankle Orthopaedics, 8. https://doi.org/10.1177/2473011423S00093

Chicago

Joseph Caporusso DPM, Mph, Ms Richard Pollak DPM, David Hernandez MD, Shannon Dalton PhD, Qinfang Xiang Ph D, Saji Vijayan MBBS, and C. James Anderson DPM. 2023. “Efficacy of Collagenase Clostridium Histolyticum Injection, a Potential Nonsurgical Intralesional Treatment Option for Plantar Fibromatosis: A Randomized, Open-Label, Dose-Ranging Study.” Foot & Ankle Orthopaedics 8 (December). doi:10.1177/2473011423S00093.